Abstract:BACKGROUND: It has been well recognized that antenatal administration of dexamethasone to pregnant women at risk of preterm delivery may markedly accelerate fetal maturation and reduce the risk of adverse perinatal outcomes in their preterm infants, particularly for births before 34 weeks of gestation. Since 2015, antenatal corticosteroid administration has been extended beyond 34 weeks of gestation by clinical guidelines, as it might have beneficial effects on fetal maturation and perinatal outcomes. However, concerns regarding the potential influence of antenatal corticosteroid treatment on offspring neurodevelopment have been raised. OBJECTIVE: This study aimed to investigate whether maternal antenatal corticosteroid administration was associated with neurodevelopment in infants at 1 year of age. STUDY DESIGN: In this prospective and longitudinal birth cohort study, women were followed up throughout gestation, and their infants underwent a Bayley Scales of Infant and Toddler Development, Third Edition, screening test at 1 year of age between December 2018 and September 2020. Finally, 1609 pregnant women and 1759 infants were included in the current study. Using a generalized linear mixed model, we examined the association between antenatal corticosteroid exposure and infant neurodevelopment in cognitive, receptive communication, expressive communication, fine motor, and gross motor functions. RESULTS: Of the 1759 infants eligible for this study, 1453 (82.6%) were singletons. A total of 710 infants were exposed to antenatal corticosteroids, among whom 415 were dexamethasone exposed and 483 were prednisone exposed. Dexamethasone was prescribed most often in late pregnancy, whereas prednisone was often used before 8 weeks of gestation among women who conceived through assisted reproductive technology. Compared with those who had no exposure, antenatal corticosteroid exposure was associated with an increased risk of infants being noncompetent in the cognitive development domain after adjusting for conventional risk factors (adjusted risk ratio, 1.53; 95% confidence interval, 1.08-2.18; P=.017). For medication-specific exposure, those exposed vs not exposed to antenatal dexamethasone were 1.62-fold (95% confidence interval, 1.10-2.38; P=.014) more likely to be noncompetent in the cognitive development domain at 1 year. The association did not vary markedly between preterm and term infants, singletons and twins, or assisted reproductive technologyeconceived and spontaneously conceived infants (all P>.05 for heterogeneity). In contrast, a null association was observed for the risk of being noncompetent in any domain of neurodevelopment with antenatal prednisone exposure at early pregnancy. CONCLUSION: Here, antenatal corticosteroid, particularly dexamethasone exposure, was markedly associated with an increased risk of infants being noncompetent in the cognitive development domain at 1 year of age. These findings may provide new information when weighing the benefits and potential risks of maternal antenatal corticosteroid administration.

Associations among birthweight, adrenarche, brain morphometry and cognitive function in preterm children aged 9-11 years

Preterm birth associated alterations in brain structure, cognitive functioning and behavior in children from the ABCD dataset

Association Between Paternal Age and Birth Weight in Preterm and Full-Term Birth: A Retrospective Study

Association of birth weight with neuropsychological functioning in early adolescence: A retrospective cohort study

Association of prenatal modifiable risk factors with attention-deficit hyperactivity disorder outcomes at age 10 and 15 in an extremely low gestational age cohort

Cognition and Behavioural Development in Early Childhood: the Role of Birth Weight and Postnatal Growth

Reduced Cholinergic Basal Forebrain Integrity Links Neonatal Complications and Adult Cognitive Deficits after Premature Birth.

Association of Growth During Infancy with Neurodevelopment and Obesity in Children Born Very Preterm: The Environmental Influences on Child Health Outcomes Cohort

Associations between body weight trajectories and neurodevelopment outcomes at 24 months corrected age in very-low-birth-weight preterm infants: a group-based trajectory modelling study

Association of birthweight and risk of incident dementia: a prospective cohort study

Impact of Early-Life Weight Status on Cognitive Abilities in Children

Extensive and Interrelated Subcortical White and Gray Matter Alterations in Preterm-Born Adults

Decreased cortical thickness mediates the relationship between premature birth and cognitive performance in adulthood

Long-term brain structural and cognitive outcomes in a low-risk preterm-born sample

Aberrant cortico-thalamic structural connectivity in premature-born adults

Associations Between Antenatal Corticosteroid Exposure and Neurodevelopment in Infants

Association between parental age, brain structure, and behavioral and cognitive problems in children

Amygdala subnuclei volumes, functional connectivity, and social–emotional outcomes in children born very preterm

Associations Between Hormonal Biomarkers and Preterm Infant Health and Development During the First 2 Years After Birth

Postnatal Stature Does Not Largely Mediate the Relation between Adverse Birth Outcomes and Cognitive Development in Mid-Childhood and Early Adolescence in Rural Western China

OP01.03: Association of birthweight with neuropsychological functioning in early adolescence: a retrospective cohort study